Modelos de datos seleccionados

Debe iniciar sesión para seleccionar modelos de datos para descargar o realizar un análisis.

1 Resultados de la búsqueda.
Relevancia Evaluación Nuevo primero Antiguo primero

Efficacy and Tolerability of TREXIMA™ (sumatriptan 85mg/naproxen sodium 500mg) ID 101999 - Subject Recruitment, Randomisation Number, Investigational Product Container Number, Previous Clinical Trial Participation, Prior participation in Sumatriptan 85mg/Naproxen Sodium 500mg Tablet Studies

- 31/10/18 - 1 formulario, 6 itemgroups, 13 items, 1 idioma
Itemgroups: Administrative Data, Subject Recruitment, Randomisation Number, Investigational Product Container Number, Previous Clinical Trial Participation (Migraine Treatment), Prior Participation in Sumatriptan 85mg / Naproxen Sodium 500mg Tablet Studies
This ODM-file contains the form to document the Randomisation number, the investigational product container number, the previous clinical trial participation, the subject recruitment and the prior participation in sumatriptan 85mg/ naproxen sodium 500mg tablet studies. To be assessed at screening. Study ID: 101999 Clinical Study ID: 101999 Study Title: A randomized, double-blind, parallel group, placebo-controlled, single-attack evaluation of the efficacy and tolerability of TREXIMA™ (sumatriptan 85mg/naproxen sodium 500mg)* tablets vs placebo when administered during the mild pain phase of a migraine Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: sumatriptan Trade Name: Imitrex ,Imiject ,Imigran Study Indication: Migraine Disorders

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial